These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 16689966

  • 21. Localized nephrogenic fibrosing dermopathy: Aberrant dermal repairing?
    Deng AC, Bilu Martin D, Sina B, Gaspari A.
    J Am Acad Dermatol; 2008 Feb; 58(2):336-9. PubMed ID: 18222333
    [Abstract] [Full Text] [Related]

  • 22. Nephrogenic fibrosing dermopathy: lessons from the past.
    Swaminathan S, Leung N.
    Int J Dermatol; 2006 Jun; 45(6):639-41. PubMed ID: 16796618
    [No Abstract] [Full Text] [Related]

  • 23. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
    Grobner T.
    Nephrol Dial Transplant; 2006 Apr; 21(4):1104-8. PubMed ID: 16431890
    [No Abstract] [Full Text] [Related]

  • 24. Strong association between the use of gadolinium-based contrast agents with nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Jamboti J.
    Intern Med J; 2007 Jul; 37(7):508-9; author reply 509. PubMed ID: 17547734
    [No Abstract] [Full Text] [Related]

  • 25. [Nephrogenic systemic fibrosis].
    Adar T, Rubinger D, Lalazar G, Levi L, Mizrahi M, Bogot RN.
    Harefuah; 2008 Oct; 147(10):801-3, 837. PubMed ID: 19039911
    [Abstract] [Full Text] [Related]

  • 26. Nephrogenic fibrosing dermopathy with systemic involvement.
    Ting WW, Stone MS, Madison KC, Kurtz K.
    Arch Dermatol; 2003 Jul; 139(7):903-6. PubMed ID: 12873886
    [Abstract] [Full Text] [Related]

  • 27. Case 35-2004: nephrogenic fibrosing dermopathy.
    Cowper SE, Bucala R, LeBoit PE.
    N Engl J Med; 2005 Apr 21; 352(16):1723-4; author reply 1723-4. PubMed ID: 15846862
    [No Abstract] [Full Text] [Related]

  • 28. Nephrogenic systemic fibrosis with septal panniculitis mimicking erythema nodosum.
    Naylor E, Hu S, Robinson-Bostom L.
    J Am Acad Dermatol; 2008 Jan 21; 58(1):149-50. PubMed ID: 18158925
    [Abstract] [Full Text] [Related]

  • 29. Case 35-2004: nephrogenic fibrosing dermopathy.
    Taylor RA, Levine JM, Jimenez SA.
    N Engl J Med; 2005 Apr 21; 352(16):1723-4; author reply 1723-4. PubMed ID: 15843679
    [No Abstract] [Full Text] [Related]

  • 30. Nephrogenic fibrosing dermopathy: a case study.
    Dundová I, Treska V, Simanek V, Michal M.
    Transplant Proc; 2005 Dec 21; 37(10):4187-90. PubMed ID: 16387074
    [Abstract] [Full Text] [Related]

  • 31. Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy).
    Levine JM, Taylor RA, Elman LB, Bird SJ, Lavi E, Stolzenberg ED, McGarvey ML, Asbury AK, Jimenez SA.
    Muscle Nerve; 2004 Nov 21; 30(5):569-77. PubMed ID: 15389718
    [Abstract] [Full Text] [Related]

  • 32. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.
    Canavese C, Mereu MC, Aime S, Lazzarich E, Fenoglio R, Quaglia M, Stratta P.
    J Nephrol; 2008 Nov 21; 21(3):324-36. PubMed ID: 18587720
    [Abstract] [Full Text] [Related]

  • 33. Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature.
    Cuffy MC, Singh M, Formica R, Simmons E, Abu Alfa AK, Carlson K, Girardi M, Cowper SE, Kulkarni S.
    Nephrol Dial Transplant; 2011 Mar 21; 26(3):1099-101. PubMed ID: 21079195
    [Abstract] [Full Text] [Related]

  • 34. Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients.
    Khurram M, Skov L, Rossen K, Thomsen HS, Marckmann P.
    Scand J Urol Nephrol; 2007 Mar 21; 41(6):565-6. PubMed ID: 17934986
    [Abstract] [Full Text] [Related]

  • 35. Nephrogenic systemic fibrosis.
    Nainani N, Panesar M.
    Am J Nephrol; 2009 Mar 21; 29(1):1-9. PubMed ID: 18663283
    [Abstract] [Full Text] [Related]

  • 36. What nephrogenic fibrosing dermopathy might be.
    LeBoit PE.
    Arch Dermatol; 2003 Jul 21; 139(7):928-30. PubMed ID: 12873893
    [No Abstract] [Full Text] [Related]

  • 37. Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure--role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate.
    Yerram P, Saab G, Karuparthi PR, Hayden MR, Khanna R.
    Clin J Am Soc Nephrol; 2007 Mar 21; 2(2):258-63. PubMed ID: 17699422
    [Abstract] [Full Text] [Related]

  • 38. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
    Broome DR.
    Eur J Radiol; 2008 May 21; 66(2):230-4. PubMed ID: 18372138
    [Abstract] [Full Text] [Related]

  • 39. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review.
    Daram SR, Cortese CM, Bastani B.
    Am J Kidney Dis; 2005 Oct 21; 46(4):754-9. PubMed ID: 16183432
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.